Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Neuropharmacology|November 18, 2015
The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive ReviewAntonio Bruno, Paolo Morabito, Edoardo Spina, et al.
Human Psychopharmacology|February 8, 2012
Clinically relevant drug interactions in anxiety disordersMaria Rosaria Muscatello, Edoardo Spina, Borwin Bandelow, et al.
Eating Behaviors|January 3, 2008
Defense mechanisms in a sample of non-psychiatric obese subjectsRocco Zoccali, Antonio Bruno, Maria Rosaria Muscatello, et al.
Therapeutic Drug Monitoring|April 2, 2015
Generic Olanzapine Substitution in Patients With Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After SwitchingDomenico Italiano, Antonio Bruno, Vincenza Santoro, et al.
Pharmacological Research|October 18, 2005
Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophreniaConcetta D'Arrigo, Gaetana Migliardi, Vincenza Santoro, et al.
Therapeutic Drug Monitoring|October 14, 2006
Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorderEdoardo Spina, Concetta D'Arrigo, Gaetana Migliardi, et al.
Pharmacological Research|August 7, 2003
Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophreniaRocco Zoccali, Maria Rosaria Muscatello, Diletta La Torre, et al.
Epilepsia|April 29, 2005
Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepineMaria Rosaria Muscatello, Monica Pacetti, Massimo Cacciola, et al.
Therapeutic Drug Monitoring|October 30, 2009
Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorderEdoardo Spina, Concetta D'Arrigo, Vincenza Santoro, et al.
International Clinical Psychopharmacology|April 13, 2004
The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled studyRocco Zoccali, Maria Rosaria Muscatello, Clemente Cedro, et al.
Pageof 2